Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage Ⅲ Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma

NCT01915134 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

NCT NCT01915134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage Ⅲ Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma
Lead sponsor
Zhejiang Cancer Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2013
Completion date
December 31, 2016
Enrollment
362 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effects of chemotherapy, stage ivc nasopharyngeal carcinoma